Why Sunscreen Is a Drug in Some Markets and a Cosmetic in Others
How the US, EU, and Australia treat SPF products differently, and where sunscreen claims can knock your notification out of the cosmetic lane.
How the US, EU, and Australia treat SPF products differently, and where sunscreen claims can knock your notification out of the cosmetic lane.
Realistic lead times from Canada's fast notification system to markets that take months, so you can sequence a launch properly.
Why the same titanium dioxide powder can be treated differently depending on which market's regulator you're filing with, and why that means checking each time.
How official cosmetic notification fees and representative costs compare across Canada, the UK, Korea, China, Saudi Arabia, and an ASEAN market.
Carcinogenic, mutagenic, and reprotoxic substance restrictions don't move at the same speed everywhere, and a formula clean in one market can fail in another.
Japan's PMD Act sorts products into a quasi-drug category that sits between cosmetics and pharmaceuticals, and certain claims push you straight into it.
China's animal testing rules for cosmetics have loosened for general products, but specific categories and importer status still trigger it.
Concrete examples of how a single preservative or colorant can be freely used in one market and restricted in another.
Shows exactly which data from a Canadian CNF carries over to a UK SCPN filing and which fields, like the RP address, must be added fresh.
Explains Japan's Marketing Authorization Holder requirement and why an overseas cosmetic brand cannot legally sell there without one.
A substance restricted under Canada's Hotlist isn't automatically treated the same way under EU Annex III or the UK's equivalent list.
How ASEAN cosmetic notification actually plays out differently on the ground in Thailand versus Vietnam, despite the shared regional framework.
Halal certification for cosmetics is a commercial expectation more often than a legal one in Gulf markets, and the ingredients that draw scrutiny are specific.
China's cosmetic rules require a domestic responsible person for imported products, and that entity carries real liability. Here is what the role means in practice.
What stability data supports your PAO symbol, and why the EU, Gulf, and Asian markets expect different levels of proof.
ASEAN's cosmetic ingredient annexes closely track EU restricted and prohibited lists, but local deviations still catch exporters off guard.
Breaks down the safety assessment and efficacy evidence China expects for a cosmetic filing, and how it differs from a Western product information file.
Japan labels cosmetics in Japanese using its own standard ingredient names, which don't map one-to-one with INCI the way you'd expect.
Which claims push a product into Korea's functional cosmetic review track instead of the simpler general cosmetic route, and what that shift means.